Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

Share Price is delayed by 15 minutes
Get Live Data
620.00    0.00 (0.00%)
Bid:
610.00
Ask:
630.00
Spread: 20.00 (3.279%)
Market Cap: £208.46m
AVG Live PriceLast checked at - London Stock Exchange

Intraday Avingtrans Share Chart

Holding(s) in Company

15 Jan 2013 13:36

AVINGTRANS PLC - Holding(s) in Company

AVINGTRANS PLC - Holding(s) in Company

PR Newswire

London, January 15

For filings with the FSA include the annexFor filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer AVINGTRANS

PLC

of existing shares to which voting rights areattached: ii2. Reason for the notification (please tick the appropriate box or boxes):An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which mayresult in the acquisition of shares already issued to which voting rightsare attached

An acquisition or disposal of instruments with similar economic effect toqualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to ROYAL BANK OF CANADA

the notification obligation: iii

4. Full name of shareholder(s) RBC CEES TRUSTEE LIMITED(if different from 3.):iv RBC TRUSTEES (CI) LIMITED RBC TRUST COMPANY (INTERNATIONAL) LIMITED5. Date of the transaction and date on 20 DECEMBER 2012which the threshold is crossed orreached: v6. Date on which issuer notified: 15 JANUARY 20137. Threshold(s) that is/are crossed or 5%

reached: vi, vii

8. Notified details:

A: Voting rights attached to shares viii, ixClass/type of Situation previous Resulting situation after the triggering transactionshares to the triggering transaction if possibleusingthe ISIN CODE Number Number Number Number of voting % of voting rights of of of shares rights x Shares Voting Rights Direct Direct xi Indirect xii Direct Indirect ORDINARY SHARES 2,357,300 2,357,300 9.06% GB0009188797

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial Expiration Exercise/ Number of voting % of votinginstrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted.

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transactionType of financial Exercise Expiration Exercise/

Number of voting rights % of votinginstrument price date xvii Conversion period

instrument refers to rights xix, xx

xviii Nominal Delta Total (A+B+C)Number of voting rights Percentage of voting rights2,357,300 9.06%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

RBC cees Trustee limited, RBC Trustees (CI) limited and RBC Trust Company(International) Limited are wholly owned indirect subsidiaries of the Royal bank ofCanada.

As disclosed in the TR-1 notification made in May 2012 on behalf of Nigel Wray itwas noted that the family of Nigel Wray maintain a beneficial interest in 1,477,300shares. The shares are held by RBC Trustees (CI) limited and RBC Trust Company(International) Limited who retain control of the underlying voting rights in theircapacity as Trustee. Proxy Voting:10. Name of the proxy holder: N/A11. Number of voting rights proxy holder will cease N/A

to hold:

12. Date on which proxy holder will cease to hold N/Avoting rights: 13. Additional information: Figures are based on total number of voting rights 26,031,00014. Contact name: SCOTT ROBERTS15. Contact telephone number: (01534) 745964

Note: Annex should only be submitted to the FSA not the issuerAnnex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification obligation

Full name Royal Bank of Canada

(including legal form of legal entities)

Contact address Royal Bank Plaza, South Tower 200 Bay Street, Suite 600(registered office for legal entities) Toronto, Ontario, Canada M5J 2J5 Phone number & email Other useful information (at least legal representative for legalpersons) B: Identity of the notifier, if applicableFull name Scott Roberts Contact address 19-21 Broad Street, St Helier JERSEY JE1 8PB Phone number & email 01534 602791 Other useful information RBC Central Compliance Services (e.g. functional relationship with theperson or legal entity subject to thenotification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

Date   Source Headline
19th May 202610:20 amRNSHolding(s) in Company
14th May 202612:26 pmRNSHolding(s) in Company
12th May 20267:00 amRNSAdaptix receives CE Certification
6th May 20264:28 pmRNSHolding(s) in Company
30th Apr 20262:42 pmRNSHolding(s) in Company
30th Apr 20262:41 pmRNSExercise of Options & TVR
24th Apr 20262:54 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSStrong Nuclear Orders for Avingtrans
26th Mar 20267:00 amRNS-RScientific Magnetics Ships 20th Quantum Magnet
4th Mar 20267:00 amRNSHolding(s) in Company
25th Feb 20267:00 amRNSInterim Results
12th Feb 202611:49 amRNSHolding(s) in Company
6th Feb 202610:24 amRNSHolding(s) in Company
27th Jan 20265:42 pmRNSExercise of Options & TVR
21st Jan 20267:00 amRNSTrading Update and Notice of Results
12th Jan 20265:13 pmRNSIssue of Share Options
12th Jan 20267:00 amRNS-RMedical & Industrial Imaging Division Appointment
8th Dec 20252:34 pmRNSNotification of Major Holdings
27th Nov 20251:59 pmRNSResult of AGM - Board Appointment
14th Nov 20258:38 amRNSExercise of Options & PDMR Dealings
10th Nov 20257:00 amRNSAdaptix receives FDA 510(K) clearance
1st Oct 20254:52 pmRNSExercise of Options & Total Voting Rights
1st Oct 20253:32 pmRNSHolding(s) in Company
29th Sep 20257:00 amRNSAppointment of Medical Division CEO
24th Sep 20257:00 amRNSPreliminary results for the year ended 31 May 2025
11th Sep 20258:00 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSHayward Tyler Secures $16m Nuclear Contracts
28th Aug 20257:00 amRNSBooth Industries secures £8.5m HS2 & TfL contracts
25th Jun 20257:00 amRNSTrading Update and Notice of Results
28th May 20257:00 amRNSTrading Update
26th Feb 20257:00 amRNSInterim Results
13th Feb 20257:00 amRNSBooth Industries secures £4.5m Contract
16th Jan 20257:00 amRNSTrading Update & Notice of Results
21st Nov 20244:09 pmRNSResult of AGM
24th Oct 20249:07 amRNSHolding(s) in Company
25th Sep 20247:00 amRNSPreliminary results for the year ended 31 May 2024
3rd Jul 20247:00 amRNSPDMR Dealings
19th Jun 20247:00 amRNSTrading Update and Notice of Results
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.